QQ客服 官方微博 反馈留言

	Cefminox, a Dual Agonist of Prostacyclin Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Identified by Virtual Screening, Has Therapeutic Efficacy against Hypoxia-Induced Pulmonary Hypertension in Rats
	Xia, Jingwen; Yang, Li; Dong, Liang; Niu, Mengjie; Zhang, Shengli; Yang, Zhiwei; Wumaier, Gulinuer; Li, Ying; Wei, Xiaomin; Gong, Yi
刊名	FRONTIERS IN PHARMACOLOGY
	2018
卷号	9
关键词	hypoxia-induced pulmonary hypertension prostacyclin receptor peroxisome proliferator-activated receptor-gamma phosphatase and tensin homolog cyclic adenosine monophosphate
ISSN号	1663-9812
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3605085
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Xia, Jingwen,Yang, Li,Dong, Liang,et al. Cefminox, a Dual Agonist of Prostacyclin Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Identified by Virtual Screening, Has Therapeutic Efficacy against Hypoxia-Induced Pulmonary Hypertension in Rats[J]. FRONTIERS IN PHARMACOLOGY,2018,9.
APA	Xia, Jingwen.,Yang, Li.,Dong, Liang.,Niu, Mengjie.,Zhang, Shengli.,...&Li, Shengqing.(2018).Cefminox, a Dual Agonist of Prostacyclin Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Identified by Virtual Screening, Has Therapeutic Efficacy against Hypoxia-Induced Pulmonary Hypertension in Rats.FRONTIERS IN PHARMACOLOGY,9.
MLA	Xia, Jingwen,et al."Cefminox, a Dual Agonist of Prostacyclin Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Identified by Virtual Screening, Has Therapeutic Efficacy against Hypoxia-Induced Pulmonary Hypertension in Rats".FRONTIERS IN PHARMACOLOGY 9(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。